Chiesi Farmaceuitici, headquartered in Parma (Italy), is a research-oriented international biopharmaceutical group with 90 years of experience that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.

By adopting the legal form of Benefit Corporation in Italy, the US, France and Colombia, Chiesi’s commitment to creating shared value for society as a whole is legally binding and central to company-wide decision-making.

Chiesi Limited is headquartered in Manchester employing over 400 people.